Chemical Market Reporter - ALENDRONATE SODIUM.(Brief Article)
October 9, 2000 -- Merck & Co., Inc. has received FDA approval for Fosamax (alendronate sodium) 10 mg once daily for treatment to increase bone mass in men with...
Business Wire - Teva Announces Tentative Approval of Alendronate Sodium Tablets
December 30, 2002 -- Business Editors/Medical Writers JERUSALEM--(BUSINESS WIRE)--Dec. 30, 2002 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today...
Harvard Health Letter - New osteoporosis drug - alendronate sodium
April 1, 1996 -- A new medication that slows bone loss while increasing skeletal mass has osteoporosis experts cautiously optimistic that they are gaining ground on...
Internal Medicine News - Alendronate/vitamin D in one tablet
August 1, 2007 -- Fosamax Plus D (alendronate sodium/vitamin [D.sub.3]) tablets are approved for the treatment of osteoporosis in women after menopause and to increase...
Drug Store News - Aurobindo Pharma
September 22, 2008 -- The FDA has granted final approval to Aurobindo Pharma to market a generic version of Merck's Fosamax tablets. The tablets, whose active ingredient...
OB/GYN News - Alendronate/vitamin D in one tablet
June 1, 2005 -- Fosamax Plus D (alendronate sodium/cholecalciferol) is approved for treatment of osteoporosis in postmenopausal women. The once-weekly tablet...
M2 Presswire - Generic Fosamax Approved.
February 7, 2008 -- M2 PRESSWIRE-7 February 2008-US Food and Drug Administration: Generic Fosamax Approved(C)1994-2008 M2 COMMUNICATIONS LTD RDATE:07022008 The...
Medical Marketing and Media - More blockbusters exit as Fosamax, Advair go off-patent
March 1, 2008 -- MERCK PUT Fosamax (alendronate sodium) and its $3 billion in total 2007 sales in its rear-view mirror last month, following the lapse of patent...
HealthDay - Generic Versions of Fosamax Approved
February 6, 2008 -- The U.S. Food and Drug Administration has approved the first generic equivalents of Fosamax (alendronate sodium), Merck & Co.'s osteoporosis...
